Clinical trial
Inhibiting Histone Deacetylase: Toward Eradication of HIV
NCT00312546 is registered in ClinicalTrials.gov with University of North Carolina, Chapel Hill as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Inhibiting Histone Deacetylase: Toward Eradication of HIV
- Lead sponsor
- University of North Carolina, Chapel Hill
- Phase
- Phase 1
- Overall status
- Terminated
- Start date
- June 30, 2006
- Completion date
- October 31, 2009
- Enrollment
- 14 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.